Loading stock data…
Avanos Medical (AVNS)
$24.93-0.02 (-0.08%)
After Hours$24.93+0.00 (+0.00%)· Last close Jun 29
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Avanos Medical, Inc. in the Healthcare sector is trading at $24.93 with a market capitalization of $1.2B. The stock is currently near its 52-week high of $25.49, remaining 58.4% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $182.20M↑ | $180.90M↑ | $177.80M↑ | $175.00M↑ | $167.50M |
| Gross Profit | $94.20M↑ | $86.00M | $86.00M↓ | $92.10M↑ | $89.80M |
| Operating Income | $8.90M↑ | $2.50M↑ | $100,000↓ | $2.50M↓ | $10.30M |
| Net Income | $5.10M↑ | -$1.30M↑ | -$1.40M↑ | -$76.80M↓ | $6.60M |
Peer Comparison
JNJUNHPFE
Fundamentals
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.17B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-9.51%
Volume
Today's trading volume
494,247
Recent News
Tactile Systems Technology (TCMD) Moves 8.1% Higher: Will This Strength Last?
Tactile Systems Technology (TCMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Reasons to Retain Avanos Medical Stock in Your Portfolio for Now
AVNS' SNS momentum, Nexus Medical integration and AIP deal support growth, but tariff costs, margin pressure and PM&R weakness remain headwinds.
Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
A Look At Avanos Medical (AVNS) Valuation After Recent 3 Month Share Price Surge
Avanos Medical stock: context for recent performance Avanos Medical (AVNS) has drawn fresh attention after a strong past 3 months, during which the stock returned about 81%. That move comes alongside annual revenue of $715.9 million and a reported net loss of $74.4 million. See our latest analysis for Avanos Medical. That surge sits in contrast to a longer track record where the 1 year total shareholder return is about 100.3%, while the 3 year total shareholder return declined 2.4% and the 5...
New Strong Sell Stocks for May 15th
AVNS, BKR and CAG have been added to the Zacks Rank #5 (Strong Sell) List on May 15th, 2026.